Heparin Modulates Integrin-Mediated Cellular Adhesion: Specificity of Interactions with α and β Integrin Subunits

REFERENCES

• Aplin AE, Howe A, Alahari SK, Juliano RL (1998). Signal transduction and signal modulation by cell adhesion receptors: The role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 50: 197–263.
   PubMed Web of Science ®Google Scholar
• Au YPT, Kenagy RD, Clowes MM, Clowes AW (1993). Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis 23 Suppl 1: 177–182.
   PubMedGoogle Scholar
• Bloom L, Ingham KC, Hyner RO (1999). Fibronectin regulates assembly of actin filaments and focal contacts in cultured cells via the heparin-binding site of repeat III13. Mol Biol Cell 10: 1521–1536.
   PubMed Web of Science ®Google Scholar
• BlystoneSD, Brown EJ (1999). Integrin receptors of phagocytes. In: Advances in Cell and Molecular Biology of Membranes and Organelles, Gordon, S (ed.), JAI Press, Greenwich, CT, pp. 103–147.
   Google Scholar
• Blystone SD, Graham IL, Lindberg FP, Brown EJ (1994). Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1. J Cell Biol 127: 1129–1137.
   PubMed Web of Science ®Google Scholar
• Blystone SD, Lindberg FP, LaFlamme SE, Brown EJ (1995). Integrin beta 3 cytoplasmic tail is necessary and sufficient for regulation of alpha 5 beta 1 phagocytosis by alpha v beta 3 and integrin-associated protein. J Cell Biol 130: 745–754.
   PubMed Web of Science ®Google Scholar
• Blystone SD, Weston LK Kaplan JE (1991). Fibronectin dependent macrophage fibrin binding. Blood 78: 2900–2907.
   PubMed Web of Science ®Google Scholar
• Brown EJ, Goodwin JL (1998). Fibronectin receptors of phagocytes: Characterization of the ArgGlyAsp binding proteins of human monocytes and polymorphonuclear leukocytes. J Exp Med 167: 777–793.
   Google Scholar
• Burgess JK, Chong BH (1997). The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls. Eur J Haematol 58: 279–285.
   PubMed Web of Science ®Google Scholar
• Calvete JJ (1995). On the structure and function of platelet integrin ?I Ib?3, the fibrinogen receptor. Proc Soc Exp Biol Med 208: 346–360.
   PubMed Web of Science ®Google Scholar
• Chakrabarti B, Park JW (1980). Glycosaminoglycans: Structure and interaction. Crc Crit Rev Biochem 8: 225–313.
   PubMed Web of Science ®Google Scholar
• Chon JH, Chaikof EL (2002). A von Willebrand factorderived heparin-binding peptide regulates cell-substrate adhesive strength and chemokinesis behavior. Biochim Biophys Acta 1542: 195–208.
   PubMed Web of Science ®Google Scholar
• Clowes AW, Reidy MA (1991). Prevention of stenosis after vascular reconstruction: Pharmacologic control of intimal hyperplasia-a review. J Vasc Surg 13: 885–891.
   PubMed Web of Science ®Google Scholar
• Conrad HE (1998). Heparin-Binding Proteins. Academic Press, San Diego.
   Google Scholar
• Fannon M, Forsten KE, Nugent M (1999). Potentiation and inhibition of bfgf bindings by heparin: A model for regulation of cellular response. Biochem 39: 1434–1445.
   Web of Science ®Google Scholar
• Hocking DC, Sottile J, Reho T, Fassler R, McKeown-Longo PJ (1999). Inhibition of fibronectin matrix assembly by the heparinbinding domain of vitronectin. J Biol Chem 274: 27257–27264.
   PubMed Web of Science ®Google Scholar
• Humphries MJ (2000). Integrin structure. Biochem Soc Trans 28: 311–339.
   PubMed Web of Science ®Google Scholar
• Kloczewiak M, Hawiger J (1982). Localisation of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen. Biochem and Biophys Res Commun 107: 181–187.
   PubMed Web of Science ®Google Scholar
• Kohno M, Yokokawa K, Yasunari K, Minami M, Kano H, Mandal AK, Yoshikawa J (1998). Heparin inhibits human coronary artery smooth muscle cell migration. Metabolism 47: 1065–1069.
   PubMed Web of Science ®Google Scholar
• Koshida S, Suda Y, Sobel M, Kusumoto S (2001). Synthesis of oligomeric assemblies of a platelet-binding key disaccharide in heparin and their biological activities. Tetra Let 42: 1289–1292.
   Web of Science ®Google Scholar
• Koshida S, Suda Y, Sobel M, Ormsby J, Kusumoto S (1999). Synthesis of heparin partial structures and their binding activities to platelets. Biorganic and Med Chem Lett 9: 3127–3132.
   PubMed Web of Science ®Google Scholar
• Michalski R, Lane DA, Kakkar VV (1977). Comparison of heparin and a semi-synthetic heparin analogue, A73025. II. Some effects on platelet function. Br J Haematol 37: 247–255.
   PubMedGoogle Scholar
• Plow EF, Haas TK, Zhang L, Loftus J, Smith JW (2000). Ligand binding to integrins. J Biol Chem 275: 21785–21788.
   PubMed Web of Science ®Google Scholar
• Salzman EW, Rosenberg RD, Smith MH, Lindon JN (1980). Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 65: 64–73.
   PubMed Web of Science ®Google Scholar
• Shattil SJ (1999). Signaling through the platelet integrin alpha(IIb)beta(3): Inside-out, outside-in, and sideways. Thromb Haemostas 82: 318–325.
   PubMed Web of Science ®Google Scholar
• Snow AD, Bolender RP, Wight TN, Clowes AW(1990). Heparin modulates the composition of the extracellular matrix domain surrounding arterial smooth muscle cells. Am J Pathol 137: 313–330.
   PubMed Web of Science ®Google Scholar
• Sobel M, Fish WR, TomaN, Luo S, Bird K, Blystone SD, SudaY (2001). Heparin modulates integrin function in human platelets. J Vasc Surg 33: 587–594.
   PubMed Web of Science ®Google Scholar
• Suda Y, Marques D, Kermode JC, Kusumoto S, SobelM(1993). Structural characterization of heparin’s binding domain for human platelets. Thrombosis Res 69: 501–508.
   Google Scholar
• Woods A, McCarthy JB, Furcht LT, Couchman JR (1993). A synthetic peptide from the COOH-terminal heparin-binding domain of fibronectin promotes focal adhesion formation. Mol Biol Cell 4: 605–613.
   PubMed Web of Science ®Google Scholar
• Xiao Z, Theroux P (1998). Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor. Circul 97: 251–256.
   PubMed Web of Science ®Google Scholar
• Yatohgo TM, Izumi H, Kashiwagi H, Hayashi M (1988). Novel purification of vitronectin from human plasma by heparin affinity chromatography. Cell Struct Funct 122: 281–292.
   Google Scholar